MINNEAPOLIS--(BUSINESS WIRE)--Urologix(R), Inc. (NASDAQ:ULGX) is pleased to announce the launch of the CTC Advance ™ Short treatment catheter at the 2009 American Urological Association Annual Meeting in Chicago, Illinois being held April 25-29, 2009. In addition to this new BPH treatment catheter, we are proud to have the AUA acceptance of two moderated poster presentations highlighting the data from clinical studies of the Urologix Cooled ThermoTherapy treatment. Urologix is the pioneer of Cooled ThermoTherapy for the treatment of enlarged prostate disease in the comfortable setting of a physician's office and we are proud to highlight the newest member of our product family and the extensive peer-reviewed clinical evidence supporting the effectiveness of our technology. Urologix’ Cooled ThermoTherapy™ is a customizable and durable nonsurgical treatment for enlarged prostate disease, also known as benign prostatic hyperplasia (BPH).
